The Ritedose Corporation, a pharmaceutical manufacturer based in South Carolina, announced a $17 million investment to expand its in-house cGMP laboratory facilities, enhancing its analytical chemistry and microbiology capabilities. The expansion, set to be completed by spring 2026, will add 10,000 square feet of laboratory space, tripling the company’s current lab footprint and enabling it to support a production capacity of 2.6 billion doses annually. The project includes two phases. Pha...